Cite

HARVARD Citation

    Osawa, H. et al. (n.d.). 481PPhase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial. Annals of oncology. p. . [Online]. 
  
Back to record